STEPHANIE SIERRA: Open Payments
NPI 1447754643 · DUBLIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$812 in 48 payments from 10 companies in 2025. Trend: 2023 $367 · 2024 $737 · 2025 $812
Food & beverage: $812
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $265 |
| Neurocrine BioSciences, Inc. | 9 | $166 |
| Axsome Therapeutics, Inc. | 9 | $150 |
| Lundbeck LLC | 5 | $77 |
| Vanda Pharmaceuticals Inc. | 2 | $42 |
| Supernus Pharmaceuticals, Inc. | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Corium, LLC | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: VRAYLAR, INGREZZA, Auvelity, REXULTI, Qelbree, HETLIOZ, AUSTEDO XR, FANAPT.
Industry payments across OH — which companies pay providers there.
